TheEdgeResearch
Home / Stocks / EVE.SW

EvoNext Holdings S.A. (EVE.SW)

SIX Healthcare Biotechnology
$2.08 ▼ -3.26%
Market Cap
$15.0M
Sector
Healthcare
Industry
Biotechnology
Beta
-0.05
52-Wk Range
0.75-2.74
CEO
Gerhard Lobmaier
Country
CH
Currency
CHF

EvoNext Holdings S.A. operates in the Biotechnology industry of the Healthcare sector, headquartered in Reinach, BL, CH. The stock last traded at $2.08, down 3.26% on the session, giving a market capitalisation of $15.0M. Its beta of -0.05 implies it has historically moved less than the broad market.

Company profile
Exchange
Swiss Exchange
Employees
49
IPO date
2005-05-03
Headquarters
Reinach, BL, CH
About EvoNext Holdings S.A.

EvoNext Holdings SA is dedicated to the exploration, creation, and distribution of pioneering ingredients across the nutritional, health, and wellness domains. Founded in 2004, the company's inception is attributed to Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith. Its corporate headquarters are located in Reinach, Switzerland.

Comparable companies

EvoNext Holdings S.A. is most often compared with the following Healthcare names:

ADXN.SWBSLN.SWMOLN.SWNWRN.SWSANN.SW
More research on EVE.SW
EVE.SW technical analysis EVE.SW TheEdge Score Compare against peers
Open full interactive analysis & DCF →